Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures

The antiepileptic drug (AED) perampanel is approved in ≥40 countries as adjunctive therapy for drug‐resistant partial seizures in patients with epilepsy. This post hoc analysis of pooled data from three phase III, double‐blind, randomized studies of perampanel examines between‐gender differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazquez, Blanca, Yang, Haichen, Williams, Betsy, Zhou, Sharon, Laurenza, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744665/
https://www.ncbi.nlm.nih.gov/pubmed/26096637
http://dx.doi.org/10.1111/epi.13019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744665/
https://www.ncbi.nlm.nih.gov/pubmed/26096637
http://dx.doi.org/10.1111/epi.13019

Ejemplares similares